PLASMA CELL LEUKEMIA (PCL)
Clinical trials for PLASMA CELL LEUKEMIA (PCL) explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL LEUKEMIA (PCL) trials appear
Sign up with your email to follow new studies for PLASMA CELL LEUKEMIA (PCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare leukemia: Four-Drug cocktail targets cancer cells
Disease control Not yet recruitingThis phase 2 trial tests a new drug combination for adults newly diagnosed with primary plasma cell leukemia, a rare and aggressive blood cancer. The treatment includes CM336 (a bispecific antibody) plus three other drugs. The study aims to see how many patients achieve deep remi…
Matched conditions: PLASMA CELL LEUKEMIA (PCL)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Personalized immunotherapy strategies aim to improve outcomes for frail myeloma patients
Disease control Not yet recruitingThis phase 3 trial is for people newly diagnosed with multiple myeloma who are not healthy enough for a stem cell transplant. After six months of standard treatment with daratumumab, lenalidomide, and dexamethasone, participants are assigned to different immunotherapy combination…
Matched conditions: PLASMA CELL LEUKEMIA (PCL)
Phase: PHASE3 • Sponsor: University of Leeds • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat blood cancer
Disease control Not yet recruitingThis early-phase trial tests a personalized treatment called IASO104 for people with relapsed or refractory multiple myeloma, a blood cancer that has not responded to standard therapies. IASO104 is made from a patient's own immune cells, which are genetically modified to recogniz…
Matched conditions: PLASMA CELL LEUKEMIA (PCL)
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC